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ABSTRACT
In this commentary we discuss new findings presented by Shang et al.
regarding the role of macrophage-derived glutamine in skeletal muscle
repair. Loss-of-function of glutamate dehydrogenase in macrophages led
to an upregulation of glutamine synthesis which sustained glutamine
levels in muscle tissue and facilitated satellite cell proliferation and
differentiation.
KEYWORDS: macrophage metabolism; amino acids; muscle repair;
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Macrophages are cells of the innate immune system that play a critical
role in the regulation of inflammatory responses. Tissue resident
macrophages contribute to organ development and homeostasis, whereas
monocyte-derived macrophages are recruited upon tissue injury and
coordinate tissue inflammation and repair. Up until recently, the
inflammatory vs. reparative capacity of macrophages was often referred
to as M1 or M2 activation states. However, it is now recognized that this
terminology fails to describe the true diversity and plasticity of
macrophage subsets in vivo [1]. Irrespective, it is well accepted that
macrophages can promote tissue repair trough the clearance of dead cells,
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induction of angiogenesis, and regulation of matrix remodeling [2].
However, based on tissue location and mode of injury the mechanisms by
which

macrophages

affect

tissue

repair

may

vary.

Therefore,

understanding the precise mechanisms utilized by these phagocytes to
improve healing is of critical importance.
Over the past decade it has been appreciated that macrophage cellular
metabolism often dictates cell activation and effector functions. As an
example, inflammatory macrophages are biased towards glycolytic
metabolism whereas macrophages with reparative phenotypes tend to
rely upon mitochondrial fatty acid oxidation [3,4]. However, it has become
clear that this simple model of linking metabolic substrate use to effector
phenotype is more complex than previously appreciated [5]. In addition,
although the role of amino acid (AA) metabolism in macrophages is
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gaining more attention, relatively little is known about AAs in macrophage
activation states. That being said, the AA glutamine has long been known
to influence immune cell activation and polarization and it is for this
reason that most cell culture media contains an excess of glutamine.
However, in the in vivo setting the availability and utilization of glutamine
by macrophages in homeostasis and disease is less well understood.
Skeletal muscle injury occurs in cases of trauma, muscular dystrophy,
drug toxicity and aging. Macrophages contribute to skeletal muscle
regeneration via several mechanisms including the release of cytokines
that promote repair, such as IL-6 and TGFβ, and growth factors, including
IGF-1, that can stimulate expansion of the muscle stem cells [6–8]. In an
elegant recent study, Shang et.al. investigate the role of metabolites as
mediators of crosstalk between macrophages and muscle satellite cells, an
area which had not previously been explored. The authors describe a
novel mechanism linking macrophage glutamine metabolism to muscle
repair [9]. The authors used both cardiotoxin and femoral artery ligation
models of skeletal muscle injury and first demonstrated that mice with a
macrophage-specific knockout (KO) of glutamate dehydrogenase (Glud1),
GLUD1 KO, had improved resolution of tissue damage and earlier
restoration of functional capacity compared to wild type (WT) mice. This
occurred as a consequence of enhanced proliferation of muscle satellite
cells. Thus, perturbing macrophage glutamine metabolism enhanced
muscle repair and regeneration.
Intriguingly, macrophage recruitment and wound healing/angiogenic
capacity were similar between the genotypes. Therefore, to understand
the mechanism of this phenotype the authors performed metabolic
phenotyping of GLUD1 KO macrophages. As GLUD1 catalyzes the
conversion of glutamate to α-ketoglutarate for entry into the tricarboxylic
acid (TCA) cycle it was not surprising that KO macrophages had a ~75%
reduction in glutamine oxidation capacity. Intriguingly, the authors also
demonstrated that macrophage glutamine production increased with the
loss of GLUD1 and this was associated with an upregulation of the enzyme
glutamine synthase (GS). Macrophage-specific KO of GS in GLUD1KO mice
prevented the enhanced proliferation of muscle satellite cells that
occurred with injury. Thus, loss of GLUD1 in macrophages promoted
muscle regeneration via a GS-dependent mechanism.
To understand the potential relevance of enhanced glutamine
production to the crosstalk between macrophages and skeletal muscle
cells the authors used an in vitro co-culture system. Glutamine is known
to be important for myoblast proliferation. When WT macrophages were
cultured with myoblasts in glutamine rich media the growth of myoblasts
was diminished to levels observed under glutamine-restricted conditions.
In contrast, this did not occur when myoblasts were cultured with GLUD1
KO macrophages irrespective of the glutamine quantity added to the
media. This data suggested that under normal conditions macrophages
take up extracellular glutamine and thereby reduce the amount of this AA
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that is available for use by myoblasts. In line with this observation,
glutamine concentrations decreased in the muscle interstitial fluid
following injury in WT mice and this drop did not occur in macrophage
GLUD1 KO mice. As such, macrophages appear to compete with satellite
cells for glutamine following muscle injury, influencing muscle
regeneration.
These findings suggested a model whereby glutamine release from
GLUD1 KO macrophages enhanced glutamine availability and fueled
muscle satellite cell expansion. To explore this possibility in more detail,
the authors knocked out the primary receptor involved in glutamine
uptake, SLC1A5, in satellite cells in vitro and in vivo using a CRISPR-Cas9
approach. When satellite cell glutamine uptake was inhibited, the
beneficial phenotype observed in macrophage GLUD1 KO mice was lost,
confirming that glutamine released from macrophages was driving
muscle regeneration. Similar results were observed in GLUD1 KO mice
treated with the SLC1A5 inhibitor g-L-glutamyl-p-nitroanilide (GPNA).
Together these findings confirm that the salutary effects of GLUD1
deficiency in macrophages is dependent on glutamine delivery to satellite
cells. Interestingly, the authors also confirmed a protective effect of
macrophage GLUD1 deficiency on preservation of muscle mass with aging,
indicating possible applications of this concept outside of acute injury.
Despite the elegant mechanistic work performed by the authors, the
question remained as to whether this pathway could be translated into
therapeutics. Therefore, the investigators treated mice with the GLUD1
inhibitor R162 after muscle injury. Inhibition of this enzyme also
improved muscle regeneration and satellite cell proliferation. Moreover,
in aged mice R162 treatment for one month improved muscle mass and
exercise capacity. Thus, pharmacologic strategies targeting GLUD1 have
promise for the treatment of acute and chronic muscle injury.
The study by Shang et.al. is an exciting addition to the field of
immunometabolism. The authors likely anticipated that disrupting
glutamine oxidation in macrophages would have a direct effect on the
macrophage polarization and thereby alter the injury response. Instead,
they uncover a novel pathway whereby the release of glutamine from
macrophages into the muscle microenvironment drove regeneration and
healing. Equally as exciting, this study provides compelling evidence that
this pathway could be exploited for therapeutic purposes (Figure 1).
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Figure 1. Schematic illustrating the key findings of Shang et. al. study. In response to skeletal muscle
injury macrophages enter the tissue and glutamine levels drop. In WT mice, macrophages compete with
satellite cells (SC) for glutamine limiting the amount that is available to drive SC proliferation. In contrast,
GLUD1 KO macrophages upregulate glutamine synthesis (GS) which leads to release of glutamine into the
microenvironment. The glutamine enters SC via the receptor SLC1A5 and promotes SC proliferation,
accelerating muscle regeneration.
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